Page last updated: 2024-11-07

penicillamine and Cardiomyopathy, Hypertrophic

penicillamine has been researched along with Cardiomyopathy, Hypertrophic in 1 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Girardot, D1
Jover, B1
Moles, JP1
Deblois, D1
Moreau, P1

Other Studies

1 other study available for penicillamine and Cardiomyopathy, Hypertrophic

ArticleYear
Chronic nitric oxide synthase inhibition prevents new coronary capillary generation.
    Journal of cardiovascular pharmacology, 2004, Volume: 44, Issue:3

    Topics: Administration, Oral; Animals; Aorta; Blood Pressure; Body Mass Index; Body Weight; Capillaries; Car

2004